Dalan Animal Health Taps Dr. Erin Strait to Drive Next Wave of Innovation as Chief Scientific Officer
Dalan Animal Health, a pioneering biotechnology company developing vaccines that leverage innate immunity, announced today ...
Optimistic Buy Rating for Merck & Co. Driven by Winrevair Projections and Financial Strength
In a report released on January 24, Daina Graybosch from Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research ...
Contract Pharma2h
Touchlight Appoints Will Downie as Key Adviser
Touchlight, a leader in synthetic DNA technology, has appointed Will Downie as a key adviser to support its mission of ...
Analysts Issue Forecasts for MRK FY2029 Earnings
Analysts at Leerink Partnrs issued their FY2029 EPS estimates for shares of Merck & Co., Inc. in a research report issued to clients and investors on Friday, January 24th. Leerink Partnrs analyst D.